3/4
05:00 pm
fulc
Form 8-K Fulcrum Therapeutics, For: Feb 26
Low
Report
Form 8-K Fulcrum Therapeutics, For: Feb 26
2/25
07:21 am
fulc
Form S-8 Fulcrum Therapeutics,
Neutral
Report
Form S-8 Fulcrum Therapeutics,
2/25
07:11 am
fulc
Form 10-K Fulcrum Therapeutics, For: Dec 31
Neutral
Report
Form 10-K Fulcrum Therapeutics, For: Dec 31
2/25
07:05 am
fulc
Form 8-K Fulcrum Therapeutics, For: Feb 25
Neutral
Report
Form 8-K Fulcrum Therapeutics, For: Feb 25
2/12
09:32 am
fulc
Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: Adage Capital Management, L.P.
Medium
Report
Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: Adage Capital Management, L.P.
1/28
04:15 pm
fulc
Form 4 Fulcrum Therapeutics, For: Jan 24 Filed by: Oltmans Curtis Gale
Low
Report
Form 4 Fulcrum Therapeutics, For: Jan 24 Filed by: Oltmans Curtis Gale
1/28
04:15 pm
fulc
Form 4 Fulcrum Therapeutics, For: Jan 24 Filed by: Musso Alan A
Low
Report
Form 4 Fulcrum Therapeutics, For: Jan 24 Filed by: Musso Alan A
1/28
04:15 pm
fulc
Form 4 Fulcrum Therapeutics, For: Jan 24 Filed by: Sapir Alex
Low
Report
Form 4 Fulcrum Therapeutics, For: Jan 24 Filed by: Sapir Alex
1/28
04:15 pm
fulc
Form 4 Fulcrum Therapeutics, For: Jan 24 Filed by: Tourangeau Greg
Low
Report
Form 4 Fulcrum Therapeutics, For: Jan 24 Filed by: Tourangeau Greg
1/13
07:24 am
fulc
Form 8-K Fulcrum Therapeutics, For: Jan 13
Low
Report
Form 8-K Fulcrum Therapeutics, For: Jan 13
1/6
04:50 pm
fulc
Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Low
Report
Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC